Literature DB >> 25986504

Neuro-oncology: The many challenges of treating elderly glioblastoma patients.

Martin J van den Bent1, Jacoline E Bromberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25986504     DOI： 10.1038/nrneurol.2015.82

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

Review 1.  Optimal management of elderly patients with glioblastoma.

Authors:  Normand Laperriere; Michael Weller; Roger Stupp; James R Perry; Alba A Brandes; Wolfgang Wick; Martin J van den Bent
Journal:  Cancer Treat Rev       Date:  2012-06-19       Impact factor: 12.111

2.  Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Authors:  Annika Malmström; Bjørn Henning Grønberg; Christine Marosi; Roger Stupp; Didier Frappaz; Henrik Schultz; Ufuk Abacioglu; Björn Tavelin; Benoit Lhermitte; Monika E Hegi; Johan Rosell; Roger Henriksson
Journal:  Lancet Oncol       Date:  2012-08-08       Impact factor: 41.316

3.  Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France.

Authors:  Sonia Zouaoui; Amélie Darlix; Pascale Fabbro-Peray; Hélène Mathieu-Daudé; Valérie Rigau; Michel Fabbro; Faiza Bessaoud; Luc Taillandier; François Ducray; Fabienne Bauchet; Michel Wager; Thierry Faillot; Laurent Capelle; Hugues Loiseau; Christine Kerr; Philippe Menei; Hugues Duffau; Dominique Figarella-Branger; Olivier Chinot; Brigitte Trétarre; Luc Bauchet
Journal:  Neurosurg Rev       Date:  2014-02-14       Impact factor: 3.042

Review 4.  Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis.

Authors:  Oren J Zarnett; Arjun Sahgal; Jessica Gosio; James Perry; Mitchel S Berger; Susan Chang; Sunit Das
Journal:  JAMA Neurol       Date:  2015-05       Impact factor: 18.302

5.  Survival outcomes in elderly patients with glioblastoma.

Authors:  D S Tsang; L Khan; J R Perry; H Soliman; A Sahgal; J L Keith; T G Mainprize; S Das; L Zhang; M N Tsao
Journal:  Clin Oncol (R Coll Radiol)       Date:  2014-12-27       Impact factor: 4.126

6.  Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

Authors:  W Roa; P M A Brasher; G Bauman; M Anthes; E Bruera; A Chan; B Fisher; D Fulton; S Gulavita; C Hao; S Husain; A Murtha; K Petruk; D Stewart; P Tai; R Urtasun; J G Cairncross; P Forsyth
Journal:  J Clin Oncol       Date:  2004-03-29       Impact factor: 44.544

7.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

8.  Radiotherapy for glioblastoma in the elderly.

Authors:  Florence Keime-Guibert; Olivier Chinot; Luc Taillandier; Stéphanie Cartalat-Carel; Marc Frenay; Guy Kantor; Jean-Sébastien Guillamo; Eric Jadaud; Philippe Colin; Pierre-Yves Bondiau; Philippe Meneï; Hugues Loiseau; Valérie Bernier; Jérôme Honnorat; Maryline Barrié; Karima Mokhtari; Jean-Jacques Mazeron; Anne Bissery; Jean-Yves Delattre
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

9.  Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme.

Authors:  Angelique E Sijben; John B McIntyre; Gloria B Roldán; Jacob C Easaw; Elizabeth Yan; Peter A Forsyth; Ian F Parney; Anthony M Magliocco; Hans Bernsen; J Gregory Cairncross
Journal:  J Neurooncol       Date:  2008-04-09       Impact factor: 4.130

10.  Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

Authors:  Wolfgang Wick; Michael Platten; Christoph Meisner; Jörg Felsberg; Ghazaleh Tabatabai; Matthias Simon; Guido Nikkhah; Kirsten Papsdorf; Joachim P Steinbach; Michael Sabel; Stephanie E Combs; Jan Vesper; Christian Braun; Jürgen Meixensberger; Ralf Ketter; Regine Mayer-Steinacker; Guido Reifenberger; Michael Weller
Journal:  Lancet Oncol       Date:  2012-05-10       Impact factor: 41.316
  10 in total
  8 in total

1.  Prognostic Significance of Anatomic Origin and Evaluation of Survival Statistics of Astrocytoma Patients-a Tertiary Experience.

Authors:  Ravindra Pramod Deshpande; Chandrasekhar Y B V K; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Indian J Surg Oncol       Date:  2018-10-30

2.  Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.

Authors:  Ravindra Pramod Deshpande; Y B V K Chandra Sekhar; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

3.  Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India.

Authors:  Ravindra Pramod Deshpande; Deepak Babu; Manas Panigrahi; Y B V K Chandra Sekhar; Phanithi Prakash Babu
Journal:  J Neurooncol       Date:  2016-06-16       Impact factor: 4.130

Review 4.  Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization.

Authors:  Rong Shao; Sherry L Taylor; Dennis S Oh; Lawrence M Schwartz
Journal:  Oncotarget       Date:  2015-12-01

5.  Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients.

Authors:  Dingyuan Luo; Wei Chen; Yun Tian; Junliang Li; Xinke Xu; Cheng Chen; Fangcheng Li
Journal:  Onco Targets Ther       Date:  2017-04-18       Impact factor: 4.147

6.  Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare study.

Authors:  Debra A Goldman; Anne S Reiner; Eli L Diamond; Lisa M DeAngelis; Viviane Tabar; Katherine S Panageas
Journal:  Neurooncol Adv       Date:  2020-11-29

7.  Impact of standard care on elderly glioblastoma patients.

Authors:  Sarah Lapointe; Marie Florescu; David Simonyan; Karine Michaud
Journal:  Neurooncol Pract       Date:  2016-12-09

8.  G protein-coupled receptor kinase 6 is overexpressed in glioma and promotes glioma cell proliferation.

Authors:  Li-Quan Xu; Shu-Bin Tan; Shan Huang; He-Yuan Ding; Wen-Gang Li; Yi Zhang; Shi-Qi Li; Tao Wang
Journal:  Oncotarget       Date:  2017-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.